Squamous Cell Carcinomas of the Head and Neck

Overview

Journal BMJ

Specialty General Medicine

Date 2002 Oct 12

PMID 12376446

Citations 106

Authors

R J Sanderson

J A D Ironside

Affiliations

Soon will be listed here.

Citing Articles

Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC.

Zhang Y, Wang Y, Peng J, Zhao K, Li L, Zhang Y Front Oncol. 2025; 15:1516867.

PMID: 39990687 PMC: 11842334. DOI: 10.3389/fonc.2025.1516867.

The microRNA-6510 as a potential tumor suppressor in head and neck cancer.

Sobecka-Giel A, Ostrowska K, Golusinski W, Suchorska W, Masternak M, Golusinski P Sci Rep. 2025; 15(1):5830.

PMID: 39966442 PMC: 11836324. DOI: 10.1038/s41598-025-86796-0.

Advancements in prognostic factors and survival outcomes following pulmonary metastasectomy for head and neck cancers.

Grapatsas K, Ehle B, Dahm M, Papatriantafyllou A, Koletsis E, Mulita F Kardiochir Torakochirurgia Pol. 2025; 21(4):218-222.

PMID: 39781437 PMC: 11704745. DOI: 10.5114/kitp.2024.145835.

dia-PASEF Proteomics of Tumor and Stroma LMD Enriched from Archived HNSCC Samples.

Panigrahi A, Hunt A, Assis D, Willetts M, Kallakury B, Davidson B bioRxiv. 2024; .

PMID: 39149249 PMC: 11326218. DOI: 10.1101/2024.08.09.607341.

Genomic and single-cell characterization of patient-derived tumor organoid models of head and neck squamous cell carcinoma.

Um J, Zheng Y, Mao Q, Nam C, Zhao H, Koh Y bioRxiv. 2024; .

PMID: 39005427 PMC: 11244938. DOI: 10.1101/2024.06.28.601068.

References

Caponigro F, Massa E, Manzione L, Rosati G, Biglietto M, De Lucia L . Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG). Ann Oncol. 2001; 12(2):199-202. DOI: 10.1023/a:1008322415335. View

Qu J, Wing P, Huang Z, Kwong D, Sham J, Lee S . Preliminary study of in vivo autofluorescence of nasopharyngeal carcinoma and normal tissue. Lasers Surg Med. 2000; 26(5):432-40. DOI: 10.1002/1096-9101(2000)26:5<432::aid-lsm2>3.0.co;2-1. View

Wunsch-Filho V, de Camargo E . The burden of mouth cancer in Latin America and the Caribbean: epidemiologic issues. Semin Oncol. 2001; 28(2):158-68. DOI: 10.1053/sonc.2001.21958. View

Northrop M, FLETCHER G, Jesse R, Lindberg R . Evolution of neck disease in patients with primary squamous cell carcinoma of the oral tongue, floor of mouth, and palatine arch, and clinically positive neck nodes neither fixed nor bilateral. Cancer. 1972; 29(1):23-30. DOI: 10.1002/1097-0142(197201)29:1<23::aid-cncr2820290104>3.0.co;2-y. View

Hammerlid E, Bjordal K, Ahlner-Elmqvist M, Boysen M, Evensen J, Biorklund A . A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope. 2001; 111(4 Pt 1):669-80. DOI: 10.1097/00005537-200104000-00021. View

Wolf G, Fisher S, Hong W, Hillman R, Spaulding M, Laramore G . Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991; 324(24):1685-90. DOI: 10.1056/NEJM199106133242402. View

McGuirt W, McCabe B . Significance of node biopsy before definitive treatment of cervical metastatic carcinoma. Laryngoscope. 1978; 88(4):594-7. DOI: 10.1002/lary.1978.88.4.594. View

Steiner W, Ambrosch P, Hess C, Kron M . Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg. 2001; 124(1):58-67. DOI: 10.1067/mhn.2001.111597. View

Newkirk K, Cullen K, Harter K, Picken C, Sessions R, Davidson B . Planned neck dissection for advanced primary head and neck malignancy treated with organ preservation therapy: disease control and survival outcomes. Head Neck. 2001; 23(2):73-9. DOI: 10.1002/1097-0347(200102)23:2<73::aid-hed1001>3.0.co;2-6. View

10.

van der Riet P, Nawroz H, Hruban R, Corio R, Tokino K, Koch W . Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 1994; 54(5):1156-8. View

11.

Thames Jr H, Withers H, Peters L, FLETCHER G . Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys. 1982; 8(2):219-26. DOI: 10.1016/0360-3016(82)90517-x. View

12.

Merino O, Lindberg R, FLETCHER G . An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1977; 40(1):145-51. DOI: 10.1002/1097-0142(197707)40:1<145::aid-cncr2820400124>3.0.co;2-9. View

13.

Moore S, Johnson N, Pierce A, Wilson D . The epidemiology of mouth cancer: a review of global incidence. Oral Dis. 2000; 6(2):65-74. DOI: 10.1111/j.1601-0825.2000.tb00104.x. View

14.

Bjordal K, Ahlner-Elmqvist M, Hammerlid E, Boysen M, Evensen J, Biorklund A . A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope. 2001; 111(8):1440-52. DOI: 10.1097/00005537-200108000-00022. View

15.

Steiner W . Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol. 1993; 14(2):116-21. DOI: 10.1016/0196-0709(93)90050-h. View

16.

CAPIZZI R, OSTER W . Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. Int J Hematol. 2001; 72(4):425-35. View

17.

Overgaard J, Hansen H, Overgaard M, Bastholt L, BERTHELSEN A, Specht L . A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol. 1998; 46(2):135-46. DOI: 10.1016/s0167-8140(97)00220-x. View

18.

Khuri F, Nemunaitis J, Ganly I, Arseneau J, Tannock I, Romel L . a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med. 2000; 6(8):879-85. DOI: 10.1038/78638. View

19.

Henk J . Concomitant chemoradiation for head and neck cancer: saving lives or grays?. Clin Oncol (R Coll Radiol). 2001; 13(5):333-5. DOI: 10.1053/clon.2001.9284. View

20.

Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A . Interventions for treating oral leukoplakia. Cochrane Database Syst Rev. 2001; (4):CD001829. DOI: 10.1002/14651858.CD001829. View